ContraFect

ContraFect Book Value per Share

The Book Value per Share of ContraFect (CFRXQ) as of Oct 20, 2026 is -1.11 USD. In the previous year, Book Value per Share was 4.61 USD — a change of -124.00% (lower).

Book Value per Share

-1.11USD

YoY

-124.00%

Last updated:

Book Value per Share of ContraFect is 2022 -1.11 USD. Book Value per Share of ContraFect was 2021 4.61 USD. It decreases by -124.00% lower compared to the previous year.

The ContraFect Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2015
2.87 USD
Jan 1, 2016
1.82 USD
Jan 1, 2017
2.91 USD
Jan 1, 2018
0.52 USD
Jan 1, 2019
1.45 USD
Jan 1, 2020
1.18 USD
Jan 1, 2021
4.61 USD
Jan 1, 2022
-1.11 USD
The ContraFect Book Value per Share history
YEARBook Value per ShareYoY
-1.11USD-124.00%
4.61USD+291.28%
1.18USD-18.79%
1.45USD+180.51%
0.52USD-82.24%
2.91USD+59.87%
1.82USD-36.41%
2.87USD+19.94%
2.39USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Book Value per Share of ContraFect is -1.11 USD in 2022.

Book Value per Share of ContraFect changed from 4.61 USD to -1.11 USD, representing a -124.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share ContraFect since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ContraFect

All Key Metrics — ContraFect